Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-04

Clinical Trial Update: The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating whether Coenzyme Q10 can prevent oxaliplatin-induced peripheral neuropathy in colorectal cancer patients and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: toqa saad mohammed mohammed | Conditions: Colorectal Cancer | Phase 1 | Status: RECRUITING